If you didn't find what you were looking for, try a new search!
The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management. Horw, Switzerland, June 18, 2024 - CeQur®, a medical device company dedicated to simplifying insulin [...]
In just over a year, CeQur® has reached major milestones in financing, company growth and the pilot launch of its three-day insulin delivery device for type 2 diabetes, CeQur Simplicity™. In this interview, CEO Bradley Paddock explains how the company is [...]
Accomplished executives with decades of healthcare experience join board as CeQur Simplicity™ advances toward commercialization LUCERNE, Switzerland & MARLBOROUGH, Mass.— (BUSINESS WIRE) — CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today [...]
CeQur Raises $115 Million Series C5 Financing Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led by Credit Suisse [...]
In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its three-day insulin delivery device for type 2 diabetes. [...]
Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech [...]
US launch expected in mid-2019 – July 17, 2018 In a major positive for CeQur, the European insulin delivery start-up has acquired Calibra Finesse (One Touch Via) from J&J, the highly-anticipated three-day-wear, bolus-only (2-unit), 510(k)-cleared, super slim disposable insulin patch device. [...]
Former Worldwide VP for Regulatory Affairs at Johnson & Johnson Brings Vast Experience in Medical Device Submissions, Approvals and GMP Compliance. MONTREUX, Switzerland, April 13, 2010 – CeQur SA, a company focused on the development and commercialization of insulin delivery systems [...]